APA (7th ed.) Citation

Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, & Ioannis S. Vizirianakis. (2022). Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. MDPI AG.

Chicago Style (17th ed.) Citation

Eleftheria Galatou, Elena Mourelatou, Sophia Hatziantoniou, and Ioannis S. Vizirianakis. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. MDPI AG, 2022.

MLA (9th ed.) Citation

Eleftheria Galatou, et al. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. MDPI AG, 2022.

Warning: These citations may not always be 100% accurate.